Traders are feeling more bullish on the company recently considering the decrease in short interest. The firm saw a fall in short interest of -11.75% as of the latest report on October 31, 2017. Short shares decreased 192,805 over that period. With short interest at 1,448,381 and short average daily volume at 443,516, the short-interest ratio is 3.0 and the percentage of shorted shares was 0.03% on October 31.
There has been some selling insider activity on Dolby Laboratories (NYSE:DLB) recently. SVP, Advanced Technology Group Steven E. Forshay disclosed the sale of 30,069 shares. The shares were sold on November 3rd for an average price of $59.00. The SVP, Advanced Technology Group now owns $3,618,519 of the stock according to the SEC filing. Kevin J. Yeaman, President and CEO sold $583,800 worth of shares at an average price of $58.38 on November 2nd. Yeaman now owns $4,547,510 of stock as recorded in a recent Form 4 SEC filing.
Director N. William Jr Jasper sold 8,000 shares at an average price of $60.00 on Wed the 18th. That brings Jasper’s holdings to $420,000 as reported to the SEC.
Here are a few substantial investment firms who have updated their positions. As of the end of the quarter Raymond James & Associates had acquired 13,825 shares growing its stake by 5.0%. The value in dollars increased from $13,644,000 to $16,824,000 increasing 23.3% since the last quarter. As of quarter end Baird Financial Group, Inc. had bought a total of 42,174 shares growing its position 107.6%. The value of the investment in (DLB) went from $1,918,000 to $4,680,000 a change of 144.0% quarter over quarter.
Alliancebernstein L.P. expanded its investment by buying 326,071 shares an increase of 35.9% from 06/30/2017 to 09/30/2017. Alliancebernstein L.P. controls 1,234,060 shares valued at $70,983,000. The total value of its holdings increased 59.7%. As of the end of the quarter Timucuan Asset Management Inc/fl had bought 41,043 shares growing its holdings by 3.5%. The value of the investment in Dolby Laboratories increased from $57,394,000 to $69,790,000 a change of $12,396,000 for the reporting period.
October 26 investment analysts at B. Riley made no change to the company rating of “Buy” targeting a price of $65.50. B. Riley released research on DLB and giving a rating of “Buy” and setting a price target of $66.00.
On September 14 B. Riley maintained a stock rating of “Buy” with a current price target of $61.50. September 13 investment analysts at Piper Jaffray Companies held the stock rating at “Hold” projecting a price of $52.00.
On September 13 Dougherty & Co made no change to the stock rating of “Buy” projecting a price of $63.00. On August 18, 2017 B. Riley released guidance on DLB with a rating of “Buy” and price target of $62.00.
The company is down by 0.08% percent from yesterday’s close. The P/E ratio is 31.41 and the market cap of the company is 6.22B. As of the latest earnings report the EPS was $1.94 with 57.89M shares presently outstanding.
Dolby Laboratories, Inc., launched on September 1, 2004, designs and manufactures audio and imaging products for the cinema, television, broadcast and entertainment industries. The Business’s products are used in content creation, distribution and playback to manage image and sound quality, and transmission and playback. The Business’s products for cinema include Digital Cinema Servers and Cinema Audio Products, and for broadcast and other include Dolby Conference Phone and Other Products. The Business’s Digital Cinema Server products are used to load, store, decrypt, decode and watermark digital film files for presentation on digital cinema projectors. It also provides products that encrypt, encode and package digital film data for distribution..